Vascarta Inc. — Form D/A
Vascarta Inc. of SUMMIT, NJ, a company, filed a Form D amendment with the SEC on 2021-04-01. The offering totals $1.0M, of which $649K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-04-01
- Form: D/A
- Accession: 0001823616-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $649K
- Remaining: $352K
- Minimum investment: $25K
- Investors: 13
- Date of first sale: 2020-08-25
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-375190
Issuer
- Name: Vascarta Inc.
- CIK: 0001823616
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 4 CHATHAM ROAD, SUMMIT, NJ, 07901
- Phone: 9733217521
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Joel Friedman, MD, PhD | Director | Summit, NJ |
| Joel Friedman, MD, PhD | Executive Officer | Summit, NJ |
| Graeme Silbert | Executive Officer | Summit, NJ |
| Travis Gering | Director | Summit, NJ |
| Travis Gering | Executive Officer | Summit, NJ |
| Richard Prince, PhD | Director | Summit, NJ |
| Richard Prince, PhD | Executive Officer | Summit, NJ |
Other filings by this issuer (3)
More